EVGENIA O'NEIL: Open Payments
NPI 1972992865 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 23 payments from 14 companies in 2025. Trend: 2023 $661 · 2024 $642 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $124 |
| Amgen Inc. | 4 | $83 |
| Lilly USA, LLC | 2 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Vifor Pharma, Inc. | 2 | $43 |
| Ardelyx, Inc. | 2 | $39 |
| Travere Therapeutics, Inc. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: Ozempic, JARDIANCE, TAVNEOS, JYNARQUE, Veltassa, IBSRELA, UPLIZNA, Kerendia.
Industry payments across DE — which companies pay providers there.
